DOI QR코드

DOI QR Code

Glutathione S-transferase M1 Null Genotype and Hepatocellular Carcinoma Susceptibility in China and India: Evidence from an Updated Meta-analysis

  • Liu, Hong-Zhou (Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University) ;
  • Peng, Jie (Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University) ;
  • Peng, Chun-Yan (Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University) ;
  • Yan, Ming (Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University) ;
  • Zheng, Fang (Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University)
  • Published : 2014.06.30

Abstract

Background: Glutathione S-transferase M1 (GSTM1) have been reported to be associated with hepatocellular carcinoma. However, the effect of the GSTMl null genotype was divergent in the literature and we therefore performed the present meta-analysis to explore the relationship in detail. Materials and Metbods: Reported studies were searched from 1990 to March 1, 2014 in PubMed and Wanfang Med Online. The total odds oatio (OR) and 95% CI were calculated and analyzed by Review Manager 5.1 and STATE 12. Results: Total OR was calculated from 26 articles with 3,769 cases and 5,517 controls and the association proved significant (OR [95%CI]=1.50 [1.25, 1.80], P<0.05) in the Chinese population. However, there was no significant association between hepatocellular carcinoma risk among subjects carrying the GSTM1 null genotype (OR [95%CI]=1.20 [0.88-1.64], P=0.24) in subgroups of publication in English and in Indian populations (OR [95%CI]=1.80 [0.80-4.20], P=0.15). Conclusions: The GSTM1 deletion polymorphism might not have a significant effect on the susceptibility of hepatocellular carcinoma overall.

References

  1. Yang ZG, Xie YA, Kuang ZP, et al (2009). Relationship between genetic polymorphisms of glutathione-S-transferase M1, T1 genes and susceptibility to hepatocelhilar carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region. Chin J Cancer Prev Treat, 16, 970-3 (in Chinese).
  2. Zhang YC, Deng CS, Zhu YQ (2005). Study on genetic polymorphisms of xenobiotica metabolizing enzymes in hepatitis B virus-associated hepatic diseases. J Wenzhou Med Coll, 35, 464-7 (in Chinese).
  3. Wang B, Huang G, Wang D, et al (2010). Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis. J Hepatology, 53, 508-18. https://doi.org/10.1016/j.jhep.2010.03.026
  4. Xiao KY, Li LQ, Peng MH, et al (2011). Gene polymorphisms of GSTM1 and GSTT1 in the clustering families of hepatocellular carcinoma. Chin J Oncol Prev Treat, 3, 287- 90 (in Chinese).
  5. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al (1995). Cytochrome P450 2El and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109, 1266-73. https://doi.org/10.1016/0016-5085(95)90587-1
  6. Yu MW, Chiu YH, Chiang YC, et al (1999). Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol, 149, 621-9. https://doi.org/10.1093/oxfordjournals.aje.a009862
  7. Yu L, Wang CY, Xi B, et al (2011). GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol, 17, 3248-56
  8. Zhu WC, Chen Q, Luo CL, et al (2001). Relationship study between gene polymorphism of CYP1A1, GSTM1 and genetic susceptibility of primary hepatocellar carcinoma. China J Cancer Prevt, 8, 572-4 (in Chinese).
  9. Zhu MH, Chen XH, Zhou LF (2005). Association of genetic polymorphisms in glutathione S-transfereses M1 with hepatitis B-related hepatoeellular carcinoma. J Zhejiang Univ (Med Sci), 34, 126-30 (in Chinese).
  10. Sun CA, Wang LY, Chen CJ, et al (2001). Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis, 22, 1289-94. https://doi.org/10.1093/carcin/22.8.1289
  11. McGlynn KA, Hunter K, LeVoyer T, et al (2003). Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res, 63, 4594-601.
  12. Ma DL, Chen YX, Li Y, et al (2005). Glutathione-S-transferase M1 and T1 polymorphisms (deficiency) and susceptibility to liver cancer in hepatitis B surface antigen positive (HBsAg positive) population. Guangxi Med J, 27, 656-7 (in Chinese).
  13. Peng J, Liu HZ, Zhu YJ (2014). Null glutathione S-transferase T1 and M1 genotypes and oral cancer susceptibility in China and India--a meta-analysis. Asian Pac J Cancer Prev, 15, 287-90. https://doi.org/10.7314/APJCP.2014.15.1.287
  14. Sarma MP, Asim M, Medhi S, Bharathi T, Kar P (2012). Hepatitis C virus related hepatocellular carcinoma: a case control study from India. J Med Virol, 84, 1009-17. https://doi.org/10.1002/jmv.23290
  15. Tang YT, Li XP, Liu TQ, et al (2012). A study of genetic polymorphisms of glutathione S-transferase in patients with hepatocellular carcinoma. Chin J Lab Diagn, 16, 660-1 (in Chinese).
  16. Wu HL, Chen MN, Liu PX, et al (2000). Relationship between GSTM1 gene polymorphism and genetic susceptibility to primary hepatocellular carcinoma. Pract J Cancer, 15, 463-5 (in Chinese).
  17. Wei YP, Ma Y, Deng ZL (2003). Genetic polymorphisms of glutathione-S-transferase M1 and T1 and the risk of hepatocellular carcinoma. Tumor, 23, 464-6 (in Chinese).
  18. Wei YP, Long XD, Liu ZG, et al (2010). Genetic polymorphism of glutathione-S.transferase M1 and T1 in hepatocellular carcinoma and nasopharyngeal carcinoma. J Cancer Prev Treat, 37, 1162-5 (in Chinese).
  19. Long XD, Ma Y, Wei YP, et a; (2005). Study on the detoxication gene gstM1, gstT1 and susceptibility to aflatoxin B1-related hepatocellular carcinoma in guangxi. Chin J Epidemiol, 26, 777-81 (in Chinese).
  20. Kao CC, Chen MK, Kuo WH, et al (2010). Influence of glutathione-S-transferase theta (GSTT1) and mu (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan. J Stag Oncol, 102, 301-7.
  21. Liu CZ, Bian JC, Jiang F, et al (2002). Genetic polymorphism of glutathione S-transferase M1, T1, P1 on susceptibility hepatocellular carcinoma. China Publ Health, 18, 935-6 (in Chinese).
  22. Li SP, Wu JZ, Ding JH, et al (2004). Impact of genetic polymorphisms of glutathione S-transferase T1, M1 on the risk of primary hepatocellular carcinoma in alcohol drinkers. Pract J Cancer, 19, 229-32 (in Chinese).
  23. Long XD, Ma Y, Wei YP, et al (2006). The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population,China. Hepatol Res, 36, 48-55. https://doi.org/10.1016/j.hepres.2006.06.004
  24. Li CG, Zhao ZM, Hu MG, Liu R (2012). Predictive role of glutathione-S-transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma. Asian Pacific of Cancer Prev, 13, 3247-52. https://doi.org/10.7314/APJCP.2012.13.7.3247
  25. Liu K, Zhang L, Lin XL, et al (2013). Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in chinese population evaluated by an updated systematic meta-analysis. Plos One, 8, 57043. https://doi.org/10.1371/journal.pone.0057043
  26. Liu HZ, Peng J, Zheng F, Wang CH, Han MJ (2013). Lack of assocation of glutathione S-transferase T1 gene null and susceptibility to lung cancer in China: A meta-analysis. Asian Pac J Cancer Prev, 14, 7215-9 https://doi.org/10.7314/APJCP.2013.14.12.7215
  27. Lakkakula S, Maram R, Munirajan AK, et al (2013). Functional PstI/RsaI polymorphisms in the CYP2E1Gene among South Indian Populations. Asian Pac J Cancer Prev, 14, 179-82. https://doi.org/10.7314/APJCP.2013.14.1.179
  28. Deng ZL, Wei YP, Ma Y (2005). Genetic deletion of GSTM1 and GSTT1 detoxicated enzymes in relation to hepatocellular carcinoma in Guangxi. Guangxi Sci, 12, 55-7 (in Chinese).
  29. Dong CH, Zi XL, Yu SZ, et al (1997). Relationship between deletion of glutathione S-transferase gene and susceptibility to primary hepatocellular carcinoma. Chin Pub Health J, 16, 141-2 (in Chinese).
  30. Deng ZL, Wei YP, Ma Y (2001). Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma. Chin J Oncol, 23, 477-9 (in Chinese).
  31. Deng ZL, Wei YP, Ma Y (2005). Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World J Gastroenterol, 11, 272-4. https://doi.org/10.3748/wjg.v11.i2.272
  32. Guo HY, Bian JC, Jiang F, et al (2005). The null genotypes of GSTM1 and GSTT1 and the genetic susceptibility of primary liver cancer in Luoyang. Tumor, 25, 58-61 (in Chinese).
  33. Hu Y, Shen FM (1997). Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249. Chin J Med Genet, 14, 76-8 (in Chinese).
  34. He SJ, Tan JR, Gu YY, et al (2005). Genetic polymorphism analysis of GSTM1, GSTT1 in patients with hepatocellular carcinoma. J Guangxi Med Univ, 22, 875-7 (in Chinese).
  35. Jeng JE, Tsai MF, Tsai HR, et al (2014). Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42. https://doi.org/10.7314/APJCP.2014.15.2.637
  36. Kiran M, Chawla YK, Kaur J (2008). Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viralrelated hepatocellular carcinoma risk in India. DNA Cell Biol, 27, 687-94. https://doi.org/10.1089/dna.2008.0805
  37. Chen SY, Wang LY, Lunn RM, et al (2002). Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer, 99, 14-21. https://doi.org/10.1002/ijc.10291
  38. Asim M, Khan LA, Husain SA, et al (2010). Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers, 28, 369-76. https://doi.org/10.1155/2010/328408
  39. Bian JC, Wang JB, Wu Y, et al (1996). Relationship between GSTM1 null genotype and genetic susceptibility to primary hepatocellular carcmoma. Chin J Med Genet, 13, 353-6 (in Chinese).
  40. Bian JC, Shen FM, Shen L, et al (2000). Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. World J Gastroenterol, 6, 228-30.
  41. Chen CC, Yang SY, Liu CJ, et al (2005). Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol, 34, 1310-8. https://doi.org/10.1093/ije/dyi191
  42. Chen YY, Ding F, Xie YA (2012). Study on gene polymorphisms of glutathione S-transferase GSTM1 and GSTT1 in high-risk families for liver cancer in Fusui county, Guangxi. Chin J Oncol Prev Treat, 4, 140-4.
  43. Chen J, Ma L, Peng NF, Wang SJ, Li LQ (2012). A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Mol Biol Rep, 39, 10383-93. https://doi.org/10.1007/s11033-012-1917-0
  44. Dong CH, Yu SZ, Chen GC, et al (1997). Polymorphisms of GSTTl and M1 genotypes and their effects on elevated aflatoxin exposure and increased risk of hepatoeellular carcinoma. J Cancer Prev Treat, 24, 327-9 (in Chinese).

Cited by

  1. Independent and Additive Interaction Between Tumor Necrosis Factor β +252 Polymorphisms and Chronic Hepatitis B and C Virus Infection on Risk and Prognosis of Hepatocellular Carcinoma: a Case-Control Study vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10209
  2. Glutathione S-transferase T1 and M1 null genotypes and Parkinson’s disease risk: evidence from an updated meta-analysis vol.36, pp.9, 2015, https://doi.org/10.1007/s10072-015-2159-4
  3. EHHM, a novel phenolic natural product from Livistona chinensis, induces autophagy-related apoptosis in hepatocellular carcinoma cells vol.12, pp.5, 2016, https://doi.org/10.3892/ol.2016.5178